Leavitt Equity Partners (LEP), a value-add healthcare focused private equity firm, has closed its third fund, Leavitt Equity Partners III (LEP III), with over $180m in capital commitments ahead of its initial $150m target.
As with predecessor funds, LEP III invests in lower middle-market healthcare companies with a focus on services, care models, and technologies that bring value to healthcare in the form of lower costs, better quality, and better access.
Dorsey & Whitney served as legal advisors to Leavitt Equity Partners in the formation of LEP III.
